Email this page to a friend. Bookmark this page.Print this page.
NEWS | CONTACT US

  • Home Page
  • Case Studies
    • Pressure Ulcers
      • Pressure Ulcers
      • Pressure Ulcers
      • Diabetic Foot Ulcers
      • Diabetic Foot Ulcers
      • Diabetic Foot Ulcers
      • Diabetic Foot Ulcers
      • Diabetic Foot Ulcers
      • Diabetic Foot Ulcers
    • Surgical Wounds
      • Mohs Surgery
      • Wound Dehiscence
      • Mohs Surgery
    • Venous Ulcers
  • About Excellagen
  • News
  • Publications and Meetings
  • Science - How Does Formulated Collagen Work
  • FAQ
  • Physician Information
  • Product Literature
  • Partnering
    • AvKARE
  • Distributor Opportunities
  • Contact Us
Learn more about Excellagen Watch a video about Excellagen
Wound Deshiscence Case Study, Steven Smith, MD, Wellesley, MA
Pretreatment (16.2 cm2) Wound Extends to Fascia

Pretreatment (16.2 cm2)
Wound Extends to Fascia

Week 4 Wound Fully Granulated

Week 4
Wound Fully Granulated


Week 9 (0.6 cm2)

Week 9
(0.6 cm2)

Week 11 Fully Epithelialized

Week 11
Fully Epithelialized


Patient Data
Age
94
Sex
Female
General Health Status
Diabetes, Hypertension, MRSA
Initial Wound Status Dehiscence with significant tissue necrosis
following postoperative MRSA infection
of Mohs surgical site
Surgical Site Right lateral lower leg
Excellagen Treatment Weekly for 4 weeks followed by twice daily
application of Bacitracin ointment

Excellagen is indicated for the management of wounds. Although many patients benefit from the use of the product, results may vary. Please see full prescribing information.